17.12.2012 Views

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Penetratins 47<br />

2.5.3.2 Oligonucleotides<br />

As in every antisense strategy, there is no general rule for obtention of a biological<br />

effect. For example, the abundance of the target mRNA, the stability of the cognate<br />

protein, and the percentage of inhibition necessary to obtain an effect are usual<br />

limiting factors. However, several parameters must be considered. The design of the<br />

oligonucleotide must minimize the possibility of secondary structure formation and<br />

of cross-hybridization with other RNAs. The site of translation start is often chosen<br />

as a target but, when possible, it is preferable to test several oligonucleotides that<br />

hybridize with different portions of the target mRNA. Fifteen to twenty-five base<br />

oligonucleotides are usually adequate. Longer oligonucleotides are not always more<br />

efficient and can reduce the efficacy of internalization. Phosphorothioate analogues<br />

of oligonucleotides with a longer half-life can be used, but precipitation with the<br />

vector often occurs during the coupling reaction. The concentration of coupled<br />

oligonucleotide hybrids is variable; as a general rule, the coupled oligonucleotide<br />

is 100- to 1000-fold more active than the uncoupled oligonucleotide. Generally,<br />

maximal effects are obtained with 10 to 100 nM and targeted proteins are downregulated<br />

after 1 to 3 h of treatment.<br />

2.5.3.3 Peptide Nucleic Acids<br />

According to the technical data available for the PNA–penetratin hybrids, no toxicity<br />

was observed for concentrations up to 150 µM with 21 mer PNAs. Concentrations<br />

used range ex vivo from 35 to 350 nM; the only in vivo study reports the use of<br />

150 µM of PNA–penetratin conjugate delivered by intrathecal injections to target<br />

the galanin receptor in rat CNS. Biological effects were obtained ex vivo from 30<br />

min to 5 h following treatment, and in vivo after 48 h of treatment. 67<br />

2.5.3.4 Drugs<br />

Two publications reported targeting penetratin-coupled anticancer drug doxorubicin<br />

ex vivo in transformed K562 human cells and in vivo through BBB of rats. Maximal<br />

biological effect (killing of transformed cells) was obtained ex vivo after 48 h of<br />

treatment (4 µM of hybrid peptide vs. 120 µM of free doxorubicin). 73 Doxorubicin<br />

transfer through BBB was 20-fold more efficient when coupled to penetratin than<br />

uncoupled. Delivery into the brain was observed rapidly after the intravenous injection<br />

of 2.5 mg peptide/kg body weight, within 30 min after the injection. 56,57,78,80-83<br />

REFERENCES<br />

1. Gehring, W.J. et al., Homeodomain-DNA recognition, Cell, 78, 211, 1994.<br />

2. Doe, C.Q. and Scott, M.P., Segmentation and homeotic gene function in the developing<br />

nervous system of Drosophila, Trends Neurosci., 11, 101, 1988.<br />

3. Doe, C.Q. et al., Control of neuronal fate by the Drosophila segmentation gene evenskipped,<br />

Nature, 333, 376, 1988.<br />

4. Le Mouellic, H. et al., Homeosis in the mouse induced by a null mutation in the Hox-<br />

3.1 gene, Cell, 69, 251, 1992.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!